[1]郭　宇,申勇智,刘丽娜,等.芪明颗粒联合重组人表皮生长因子滴眼液治疗糖尿病患者青光眼白内障联合手术后眼干燥症疗效观察[J].新乡医学院学报,2021,38(2):124-128.[doi:10.7683/xxyxyxb.2021.02.005]
　GUO Yu,SHEN Yongzhi,LIU Lina,et al.Effect of Qiming granule combined with recombinant human epidermal growth factor eyedrops in the treatment of xerophthalmia after combined operation of glaucoma and cataract in patients with diabetes mellitus[J].Journal of Xinxiang Medical University,2021,38(2):124-128.[doi:10.7683/xxyxyxb.2021.02.005]
点击复制

芪明颗粒联合重组人表皮生长因子滴眼液治疗糖尿病患者青光眼白内障联合手术后眼干燥症疗效观察
分享到：

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
38
期数:
2021年2
页码:
124-128
栏目:
临床研究
出版日期:
2021-02-05

文章信息/Info

Title:
Effect of Qiming granule combined with recombinant human epidermal growth factor eyedrops in the treatment of xerophthalmia after combined operation of glaucoma and cataract in patients with diabetes mellitus
作者:
郭　宇1; 申勇智2; 刘丽娜3; 王丽坤1; 杜　鹏2
（1.河北北方学院附属第二医院眼科，河北　张家口　075100；2.张家口市宣化区人民医院五官科，河北　张家口　075100；3.张家口市第四医院眼科，河北　张家口　075000）
Author(s):
GUO Yu1; SHEN Yongzhi2; LIU Lina3; WANG Likun1; DU Peng2
(1.Department of Ophtalmology,the Second Affiliated Hospital of Hebei North University,Zhangjiakou 075100,Hebei Province,China2.Department of Ophthalmology and Otorhinolaryngology,Xuanhua District People′s Hospital in Zhangjiakou City,Zhangjiakou 075100,Hebei Province,China3.Department of Ophtalmology,the Fourth Hospital of Zhangjiakou City,Zhangjiakou 075000,Hebei Province,China)
关键词:
糖尿病; 眼干燥症; 芪明颗粒; 重组人表皮生长因子滴眼液
Keywords:
diabetes mellitusxerophthalmiaQiming granulerecombinant human epidermal growth factor eyedrops
分类号:
R779.6；R587.2
DOI:
10.7683/xxyxyxb.2021.02.005
文献标志码:
A
摘要:
目的　探讨芪明颗粒联合重组人表皮生长因子滴眼液治疗糖尿病患者青光眼白内障联合手术后眼干燥症的临床效果。方法　选择2014年4月至2019年10月于河北北方学院附属第二医院眼科行青光眼白内障联合手术后发生眼干燥症的75例（75眼）糖尿病患者为研究对象，根据治疗方法将患者分为A组、B组和C组，每组25例。A组患者给予妥布霉素地塞米松滴眼液和玻璃酸钠滴眼液等常规治疗；在常规治疗基础上，B组患者给予重组人表皮生长因子滴眼液治疗，C组患者给予芪明颗粒和重组人表皮生长因子滴眼液治疗；3组患者均治疗4周。治疗前及治疗1、2、3、4周对患者进行眼干燥症症状评分和角膜荧光素染色（CFS）评分，治疗前及治疗4周后测量患者基础泪液分泌量和泪膜破裂时间，治疗4周后评定3组患者临床治疗效果。结果　治疗前3组患者的眼干燥症症状评分比较差异无统计学意义（P＞0.05）；3组患者治疗1、2、3、4周后眼干燥症症状评分均显著低于治疗前（P＜0.05）；治疗1、2、3、4周，B组和C组患者眼干燥症症状评分均显著低于A组，C组患者眼干燥症症状评分显著低于B组（P＜0.05）。治疗前3组患者泪膜破裂时间和基础泪液分泌量比较差异无统计学意义（P＞0.05）；3组患者治疗4周后泪膜破裂时间和基础泪液分泌量显著大于治疗前（P＜0.05）；治疗4周后，B组和C组患者泪膜破裂时间和基础泪液分泌量显著大于A组，C组患者泪膜破裂时间和基础泪液分泌量显著大于B组（P＜0.05）。治疗前3组患者CFS评分比较差异均无统计学意义（P＞0.05）；3组患者治疗1、2、3、4周后CFS评分显著低于治疗前（P＜0.05）；治疗1、2、3、4周后3组患者CFS评分比较差异无统计学意义（P＞0.05）。A组、B组和C组患者总有效率分别为84.00%（21/25）、92.00%（23/25）、100.00%（25/25），C组患者治疗总有效率显著高于A组和B组（χ2=10.327、5.625，P＜0.05），B组患者治疗总有效率显著高于A组（χ2=6.175，P＜0.05）。结论　芪明颗粒联合重组人表皮生长因子滴眼液可以显著改善糖尿病患者青光眼白内障联合手术后眼干燥症症状和泪膜稳定性，提高基础泪液分泌量。
Abstract:
Objective　To investigate the clinical effect of Qiming granule combined with recombinant human epidermal growth factor eyedrops in the treatment of xerophthalmia after combined operation of glaucoma and cataract in patients with diabetes mellitus.Methods　　Seventy-five patients (75 eyes) with diabetes mellitus complicated with xerophthalmia after combined operation of glaucoma and cataract in the Second Affiliated Hospital of Hebei North University from April 2014 to October 2019 were selected as the research subjects,and the patients were divided into group A,group B and group C according to the treatment methods,with 25 cases in each group.The patients in the group A were treated with conventional treatment such as tobramycin and dexamethasone eyedrops and sodium hyaluronate eyedrops.On the basis of conventional treatment,the patients in the group B were treated with recombinant human epidermal growth factor eyedrops,while the patients in the group C were treated with Qiming granule and recombinant human epidermal growth factor eyedrops.The patients in the three groups were treated for 4 weeks.The symptom score of xerophthalmia and the corneal fluorescein staining (CFS) score of the patients were performed before treatment and after 1,2,3,4 weeks of treatment.The basic lacrimal secretion and breakup time of tear film were measured before and after 4 weeks of treatment.The clinical effects of the patients in the three groups were evaluated after 4 weeks of treatment.Results　There was no significant difference in the symptom score of xerophthalmia among the three groups before treatment (P>0.05).The symptom score of xerophthalmia of the patients after 1,2,3 and 4 weeks of treatment was significantly lower than that before treatment in the three groups (P＜0.05).After 1,2,3 and 4 weeks of treatment,the symptom score of xerophthalmia of the patients in the group B and group C was significantly lower than that in the group A,and the symptom score of xerophthalmia of the patients in the group C was significantly lower than that in the group B (P＜0.05).There was no significant difference in the breakup time of tear film and the basic lacrimal secretion of the patients among the three groups before treatment (P>0.05).The breakup time of tear film and the basic lacrimal secretion of the patients after 4 weeks of treatment were significantly more than those before treatment in the three groups (P＜0.05).After 4 weeks of treatment,the breakup time of tear film and the basic lacrimal secretion of the patients in the group B and group C were significantly higher than those in the group A,and the breakup time of tear film and the basic lacrimal secretion in the group C were significantly higher than those in the group B (P＜0.05).There was no significant difference in the CFS score of the patients among the three groups before treatment (P>0.05).The CFS score of the patients after 1,2,3 and 4 weeks of treatment was significantly lower than that before treatment in the three groups (P＜0.05).There was no significant difference in CFS score among the three groups after 1,2,3 and 4 weeks of treatment (P>0.05).The total effective rate in the group A,group B and group C was 84.00% (21/25),92.00% (23/25) and 100.00% (25/25),respectively.The total effective rate in the group C was significantly higher than that in the group A and group B (χ2=10.327,5.625;P＜0.05).The total effective rate in the group B was significantly higher than that in the group A (χ2=6.175,P＜0.05).Conclusion　Qiming granule combined with recombinant human epidermal growth factor eyedrops can significantly improve the symptoms of xerophthalmia and the stability of tear film,and increase the basic lacrimal secretion in patients with diabetes mellitus complicated with xerophthalmia after combined operation of glaucoma and cataract.

参考文献/References:

［1］　梁静.闭角型青光眼并发白内障的三联手术疗效及安全性分析［J］.现代临床医学，2020，46（1）：24-26.
［2］　邵毅，石文卿.2018美国眼科学会干眼指南解读［J］.眼科新进展，2019，39（12）：1101-1104，1110．
［3］　王文芳，齐海霞，巴元森.rhEGF滴眼液与玻璃酸钠滴眼液治疗干眼症并角膜上皮损伤疗效比较［J］.内科，2017，12（4）：566-567，576.
［4］　靳素娟.玻璃酸钠联合rhEGF滴眼液治疗白内障术后干眼症泪膜的临床效果［J］.临床医学，2018，38（3）：114-115.
［5］　王松.加减杞菊地黄汤联合针刺治疗肝肾亏虚型干眼症的临床观察［J］.湖北中医杂志，2016，38（2）：54-56.
［6］　中华医学会糖尿病学分会.中国2型糖尿病防治指南（2013年版）［J］.中国糖尿病杂志，2014，22（8）：2-42.
［7］　ZHANG M,XIANG Y H.Analysis of ocular surface dysfunction in patients with type 2 diabetes mellitus［J］.Int Eye Sci,2020,20(11):1853-1857.
［8］　中华医学会眼科学分会角膜病学组.干眼症临床诊疗专家共识（2013年) ［J］.中华眼科杂志，2013，49（1）：73-75.
［9］　MCMONNIES C W.Key questions in dry eye history［J］.J Am Ovtom Assoc,1986,57(7):512-517．
［10］　吴娜，张蕊.青光眼合并白内障患者联合手术后眼表泪膜变化临床观察［J］.山东医药，2014，54（2）：75-77.
［11］　陈伽俐，窦晓燕，李林.重组人表皮生长因子联合卡波姆凝胶治疗超声乳化白内障吸除术后干眼症疗效观察［J］.新乡医学院学报，2019，36（6）：525-528.
［12］　李俊杰，谢擎，孙志敏.重组人表皮生长因子滴眼液联合卡波姆眼用凝胶对白内障超声乳化吸除术后干眼症患者炎症及氧化应激水平的影响［J］.广西医学，2020，42（1）：33-36，40.
［13］　LIU H,SHENG M,LIU Y,et al．Expression of SIRT1 and oxidative stress in diabetic dry eye［J］.Int J Clin Exp Pathol,2015,8(6):7644-7653.
［14］　余勇军，曾志成.杞菊地黄丸联合人工泪液局部滴眼治疗肝肾阴虚型干眼症临床观察［J］.内蒙古中医药，2012，31（4）：26-27.
［15］　UCHINO Y,KAWAKITA T,MIYAZAWA M,et al.Oxidative stress induced inflammation initiates functional decline of tear production［J］.PLoS One,2012,7(10):e45805.
［16］　王云鹏，查志伟，雷雨，等.糖化血红蛋白（HbA1c）水平对2型糖尿病患者干眼症状及体征的影响［J］.眼科新进展，2020，40（6）：562-565．
［17］　邵毅，吴康瑞，叶蕾.干眼的发病机制及治疗研究进展［J］.眼科新进展，2020，40（4）：301-306．
［18］　EL ANNAN J,GOYAL S,ZHANG Q,et al.Regulation of T-cell chemotaxis by programmed death-ligand 1 (PD-L1) in dry eye-associated corneal inflammation［J］.Invest Ophthalmol Vis Sci,2010,51(7):3418-3423．
［19］　BIKKER A,VAN WOERKOM J M,KRUIZE A A,et al.Increased expression of interleukin-7 in labial salivary glands of patients with primary Sjogren′s syndrome correlates with increased inflammation［J］．Arthritis Rheum,2010,62(4):969-977.
［20］　LENNARD C M,MANN E A,SUN L L,et al.Interleukin-1β,interleukin-5,interleukin-6,interleukin-8,and tumor necrosis factor-α in chronic sinusitis:response to systemic corticosteroids［J］.Am J Rhinol,2000,14(6):367-373.
［21］　赵智华，李科军，赵晓彬，等.芪明颗粒联合人工泪液、非甾体消炎药滴眼液治疗对超声乳化手术术后干眼症患者损伤角膜上皮的作用［J］.世界中医药，2017，12（12）：2971-2974.
［22］　赵智华，樊芳，马清敏，等.芪明颗粒的应用可改善T2DM患者眼科手术后干眼症［J］.基因组学与应用生物学，2018，37（1）：80-86.

相似文献/References:

[1]马晓军,霍慧春,刘娟,等.针灸联合中药对糖尿病大鼠血脂及血糖的调节作用[J].新乡医学院学报,,():000.
[2]郭永年.糖尿病氯磺丙脲酒精潮红试验[J].新乡医学院学报,1986,3(02):064.
[3]翁孝刚,郭永年,王宪波,等.复方中药渴乐饮对实验大鼠体重及血糖的影响 [J].新乡医学院学报,1994,11(02):107.
[4]郭永年,李灵敏,王伟,等.新光碘蛋的研制及其对糖尿病患者的保健作用 [J].新乡医学院学报,1994,11(04):339.
[5]翁孝刚,王宪波,郭永年,等.复方中药渴乐饮对实验大鼠胰岛B细胞形态及功能的影响[J].新乡医学院学报,1994,11(04):351.
[6]王宪波,翁孝刚,王伟,等.复方中药渴乐饮对实验大鼠的抗氧化抗疲劳作用[J].新乡医学院学报,1994,11(04):354.
[7]翁孝钢,梁荩忠,吴兆锋,等.链脲菌素实验性糖尿病大鼠组织钙调素活性的研究[J].新乡医学院学报,1995,12(03):201.
[8]王宪波,翁孝钢,郭永年,等.复方中药渴乐对实验糖尿病大鼠血脂的影响[J].新乡医学院学报,1995,12(01):018.
[9]王卫民,张清贵,王昕红,等.尿C—肽与Ⅱ型糖尿病患者的β细胞功能[J].新乡医学院学报,1996,13(01):044.
[10]索新华,陈志刚,郭永年,等.糖尿病性水疱病及其感染的临床治疗[J].新乡医学院学报,1997,14(01):057.

更新日期/Last Update: 2021-02-05